Report workspace tools

NCT04589923COMPLETEDanonymous

The Measurement of VItal SIgns by Lifelight® Data Collect Software in comparisON to the Standard of Care in Acutely Unwell Patients - The VISION-Acute Study

Sponsor

Source record

Xim Limited

Phase

Source record

registry-stage

Modality

AI-normalized

medical device

Target

AI-normalized

Lifelight® Data Collect Blood Pressure Group, Lifelight® Data Collect Oxygen Saturation Group

Indication / condition

AI-normalized

Hypertension

Intervention

Source record

Lifelight® Data Collect Blood Pressure Group, Lifelight® Data Collect Oxygen Saturation Group

Source & freshness

Source record

NCT ID

NCT04589923

Original source

ClinicalTrials.gov

Source last updated

Jul 20, 2022

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT04589923

Title

The Measurement of VItal SIgns by Lifelight® Data Collect Software in comparisON to the Standard of Care in Acutely Unwell Patients - The VISION-Acute Study

Sponsor

Xim Limited

Status

COMPLETED

Phase

registry-stage

Condition raw

Hypertension

Condition normalized

Hypertension

Modality raw

pulmonary arterial hypertension

Modality normalized

medical device

Target raw

Lifelight® Data Collect Blood Pressure Group, Lifelight® Data Collect Oxygen Saturation Group

Target normalized

Lifelight® Data Collect Blood Pressure Group, Lifelight® Data Collect Oxygen Saturation Group

Interventions

Lifelight® Data Collect Blood Pressure Group, Lifelight® Data Collect Oxygen Saturation Group

Public preview

Source record

The Measurement of VItal SIgns by Lifelight® Data Collect Software in comparisON to the Standard of Care in Acutely Unwell Patients - The VISION-Acute Study is a registry-stage clinical asset sponsored by Xim Limited in Hypertension, Hypoxia, Hypotension. SEO and diligence focus: Lifelight® Data Collect Blood Pressure Group, Lifelight® Data Collect Oxygen Saturation Group, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account

Create a free account first, then unlock a single report, buy credits or subscribe.